data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Cormedix
(NASDAQ:CRMD)
3.45
-0.17[-4.70%]
At close: Jun 24
3.4699
0.0199[0.58%]
After Hours: 5:27PM EDT
Day High/Low3.3 - 3.79
52 Week High/Low2.65 - 8.13
Open / Close3.63 / 3.45
Float / Outstanding38.7M / 39.1M
Vol / Avg.4.7M / 451K
Mkt Cap135M
P/E-
50d Avg. Price3.42
Div / Yield-
Payout Ratio-
EPS-0.18
Total Float38.7M

Cormedix (NASDAQ:CRMD), Quotes and News Summary

Cormedix (NASDAQ: CRMD)

Day High/Low3.3 - 3.79
52 Week High/Low2.65 - 8.13
Open / Close3.63 / 3.45
Float / Outstanding38.7M / 39.1M
Vol / Avg.4.7M / 451K
Mkt Cap135M
P/E-
50d Avg. Price3.42
Div / Yield-
Payout Ratio-
EPS-0.18
Total Float38.7M
Benzinga - May 17, 2022, 4:49AM
Benzinga - May 12, 2022, 5:14PM
Benzinga - May 12, 2022, 4:20PM
Benzinga - Mar 29, 2022, 4:03PM
Benzinga - Mar 28, 2022, 8:31AM
Benzinga - Mar 17, 2022, 8:33AM
Benzinga - Mar 10, 2022, 10:59AM
Benzinga - Feb 28, 2022, 12:42PM
Benzinga - Feb 28, 2022, 11:38AM
Benzinga - Feb 28, 2022, 8:32AM
Benzinga - Nov 9, 2021, 5:19PM
Benzinga - Oct 20, 2021, 8:33AM
Benzinga - Oct 4, 2021, 4:02PM
load more
Sector: Health Care.Industry: Pharmaceuticals
Cormedix Inc is a biopharmaceutical company that focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has been in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis, total parenteral nutrition, and oncology. The Neutrolin product is designed to target unmet medical needs.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-22
REV
Q1 2022Est.ActualSurprise
EPS-0.220-0.180 0.0400
REV7.636K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Cormedix Questions & Answers

Q
How do I buy Cormedix (CRMD) stock?
A

You can purchase shares of Cormedix (NASDAQ: CRMD) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Cormedix's (CRMD) competitors?
Q
What is the target price for Cormedix (CRMD) stock?
A

The latest price target for Cormedix (NASDAQ: CRMD) was reported by Needham on Friday, May 14, 2021. The analyst firm set a price target for 29.00 expecting CRMD to rise to within 12 months (a possible 740.58% upside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Cormedix (CRMD)?
A

The stock price for Cormedix (NASDAQ: CRMD) is $3.45 last updated June 24, 2022, 8:00 PM UTC.

Q
Does Cormedix (CRMD) pay a dividend?
A

There are no upcoming dividends for Cormedix.

Q
When is Cormedix (NASDAQ:CRMD) reporting earnings?
A

Cormedix’s Q2 earnings are confirmed for Monday, August 22, 2022.

Q
Is Cormedix (CRMD) going to split?
A

There is no upcoming split for Cormedix.

Q
What sector and industry does Cormedix (CRMD) operate in?
A

Cormedix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.